UPDATE 2-FDA staff flags concerns about Pfizer's quit-smoking drug study

Sept 12 (Reuters) - Pfizer Inc's trial data on

Chantix, a drug to help people quit smoking, failed to impress

U.S. Food and Drug Administration scientists, in a blow to the

company's attempts to have a serious warning removed from the

drug's label.

Read more